New study reveals long-term impacts on Stevens-Johnson syndrome survivors
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) survivors encounter rare, life-threatening drug reactions and years of physical, emotional and social consequences long after leaving the hospital, according to a study published today in JAMA Dermatology.
Investigators from Vanderbilt University Medical Center’s Center for Drug Safety and Immunology (CDSI), in collaboration with the VUMC Qualitative Research Core, conducted one of the largest qualitative studies in the United States exploring SJS/TEN recovery and long-term residual effects from the patients’ ...